68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is: Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• Female patients aged 18 and above
• ECOG score 0-2 points
• Pathological confirmation of malignant breast tumor
• Clinical axillary lymph node positivity (cN+)
• Completed at least 3 courses of neoadjuvant therapy and subjected to undergo surgical treatment
• Informed consent form signed
Locations
Other Locations
China
Shanghai Jiao Tong University School of Medicine, Ruijin Hospital
RECRUITING
Shanghai
Contact Information
Primary
Xiaosong Chen
zsj_mu@yeah.net
86-21-64370045
Time Frame
Start Date: 2024-08-30
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 150
Treatments
68Ga-FAPI PET/CT
68Ga-FAPI PET/CT
Related Therapeutic Areas
Sponsors
Leads: Kunwei Shen